Brief: Expres2ion Biotech Holding Q4 Pretax Loss Widens To SEK 6.9 Mln
Feb 26 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* EXPRES2ION BIOTECH HOLDING AB: PUBLICATION OF YEAR-END
REPORT
2019
* Q4 PRETAX LOSS SEK 6.9 MILLION VERSUS LOSS SEK 6.1 MILLION
YEAR
AGO
* Q4 TURNOVER SEK 3.6 MILLION VERSUS SEK 1.4 MILLION YEAR
AGO
Source text for Eikon: ID:nWkrbhjC5k
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations